AwardedCzechiaGoodsCZK 9,351,000
LP pro krev - lidský koagulační faktor VIII. a lidský von Willebrandův faktor v kombinaci - I.
- Published
- Published 14 April 2026
- Deadline
- Closed 14 May 2026
Overview
The Institute of Clinical and Experimental Medicine procured supplies of medicinal products for parenteral administration containing human coagulation factor VIII and human von Willebrand factor in combination (ATC B02BD06) for treating patients in approved indications. CSL BEHRING s.r.o. was awarded the contract on 19 May 2026 for 9,349,835 CZK.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 9,351,000
- Procedure
- Open
- SME suitable
- Yes
- Published
- 14 April 2026
- Deadline
- Closed
Medicinal products for the blood and blood-forming organs
Award outcome
- Awarded value
- CZK 9,349,835
- Award date
- 19 May 2026
- Contract period
- — → 28 April 2030
- CSL BEHRING s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
10 June 2026
Contract Notice
14 April 2026
Contracting authority
Institut klinické a experimentální medicíny
Procuring entityPraha, Czechia
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.